Alteration by cadmium of rat submandibular gland secretory function and the role of the l-arginine/nitric oxide pathway. 2000

M Abdollahi, and A Dehpour, and P Kazemian
Faculty of Pharmacy, Department of Toxicology and Pharmacology, Tehran University of Medical Sciences, 14155-6451, Tehran, Iran. mabdol@yahoo.com

The effects of cadmium, l-arginine (nitric oxide precursor) and N(omega)-nitro-l-arginine methyl ester (l -NAME) as a nitric oxide synthesis inhibitor and cotreatment of them on rat submandibular secretory function were studied. Pure submandibular saliva was collected intraorally by micro polyethylene cannula from anaesthetized rats using pilocarpine as secretagogue. Fourteen days treatment with 10 mg l(-1)cadmium as cadmium chloride in drinking water caused significant alterations on salivary function. Salivary flow rate, total protein concentration and amylase activity of saliva were decreased while secretion of calcium was increased by cadmium. Two weeks treatment of rats with l -arginine (2.25%) in drinking water caused an increase in submandibular gland weight. Flow rate was reduced by l-NAME. The total protein concentration of saliva was increased by l-arginine while decreased by l-NAME. Calcium concentration of saliva was reduced by l-arginine and increased by l-NAME. Cotreatment of cadmium with l-arginine prevented cadmium-induced reduction of flow rate while l-NAME cotreatment potentiated cadmium-induced reduction of flow rate. l-arginine showed a preventive effect on cadmium-induced decrease of protein concentration and reached control levels. l-arginine potentiated cadmium-induced increase of saliva calcium concentration. It is confirmed that nitric oxide (NO) has a role in salivary gland function. It is also concluded that cadmium inhibitory effects on salivary gland function are modulated by the NO system as it is observed that the cadmium inhibitory effect on submandibular gland function is diminished by l-arginine and extended by l-NAME. Considering the properties of cadmium substitution for calcium in many intracellular events, different types of alterations can be discussed.

UI MeSH Term Description Entries
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002104 Cadmium An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D013363 Submandibular Gland One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed) Submaxillary Gland,Gland, Submandibular,Gland, Submaxillary,Glands, Submandibular,Glands, Submaxillary,Submandibular Glands,Submaxillary Glands
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019331 NG-Nitroarginine Methyl Ester A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension. L-NAME,N omega-Nitro-L-arginine Methyl Ester,NG-Nitro-L-Arginine Methyl Ester,N(G)-Nitro-L-arginine Methyl Ester,N(G)-Nitroarginine Methyl Ester,N(omega)-Nitro-L-arginine Methyl Ester,NG-Nitroarginine Methyl Ester, D-Orn-Isomer,NG-Nitroarginine Methyl Ester, L-Orn-Isomer, Monohydrochloride,Methyl Ester, NG-Nitro-L-Arginine,Methyl Ester, NG-Nitroarginine,N omega Nitro L arginine Methyl Ester,NG Nitro L Arginine Methyl Ester,NG Nitroarginine Methyl Ester,NG Nitroarginine Methyl Ester, D Orn Isomer

Related Publications

M Abdollahi, and A Dehpour, and P Kazemian
January 1994, Archives of gerontology and geriatrics,
M Abdollahi, and A Dehpour, and P Kazemian
December 1993, The New England journal of medicine,
M Abdollahi, and A Dehpour, and P Kazemian
January 1993, Current opinion in nephrology and hypertension,
M Abdollahi, and A Dehpour, and P Kazemian
June 1993, Journal of hypertension,
M Abdollahi, and A Dehpour, and P Kazemian
February 2002, Pharmacological research,
M Abdollahi, and A Dehpour, and P Kazemian
October 2007, Peptides,
M Abdollahi, and A Dehpour, and P Kazemian
August 2008, Therapeutic advances in cardiovascular disease,
M Abdollahi, and A Dehpour, and P Kazemian
November 2013, Amino acids,
M Abdollahi, and A Dehpour, and P Kazemian
March 2006, Biochemical and biophysical research communications,
M Abdollahi, and A Dehpour, and P Kazemian
June 2006, Cardiovascular & hematological disorders drug targets,
Copied contents to your clipboard!